Next book

OWNING THE SUN

A PEOPLE'S HISTORY OF MONOPOLY MEDICINE FROM ASPIRIN TO COVID-19 VACCINES

A trenchant study of the dangers of turning medical knowledge into private intellectual property.

A freelance journalist faults the “fundamentally corrupt and unjust system” that allows big pharma and others to hoard scientific knowledge instead of using it for the greatest public good.

Zaitchik offers a biting study of the “double protection racket” through which drug companies benefit from government-subsidized research and then use patents to reap unseemly profits from it. Beginning with the Renaissance princes whose “royal grants” amounted to proto-patents, the author gives a dense but clear history of how scientific patents have promoted “monopoly medicine.” Zaitchik argues that patents were envisioned by the framers of the Constitution as a two-way social contract for advancing science and “useful arts” but have become a vehicle for turning vital medical knowledge into private intellectual property. That process sped up with the passage of the Bayh-Dole Act in 1980, which allowed businesses and universities to retain the rights to knowledge developed with federal funding, and it helped to make possible the “vaccine nationalism” of Operation Warp Speed. Drawing on deep research, Zaitchik knocks the halos off three prominent players in the pandemic: Pfizer (whose CEO fought generic drugs in the 1980s); Moderna (two of whose executives dumped $30 million in stock in a legal but suspiciously timed move after the company announced promising vaccine trial results); and Bill Gates, the focus of a chapter called “Pharma’s Best Friend: Bill Gates and Covid-19.” The author makes a strong case that Gates tried to undermine the efforts of experts who predicted a global vaccine supply crisis with his insistence that market forces could ensure a fair distribution of vaccines among rich and poor nations, a view that has proved “catastrophically incorrect” given that half the world’s population remains unvaccinated against Covid. While big pharma often gets the sole blame for soaring drug prices, this book is a brave and timely reminder that politicians and corporate titans have enabled its excesses.

A trenchant study of the dangers of turning medical knowledge into private intellectual property.

Pub Date: March 1, 2022

ISBN: 978-1-64009-506-9

Page Count: 304

Publisher: Counterpoint

Review Posted Online: Dec. 20, 2021

Kirkus Reviews Issue: Jan. 15, 2022

Awards & Accolades

Likes

  • Readers Vote
  • 66


Our Verdict

  • Our Verdict
  • GET IT


  • Kirkus Reviews'
    Best Books Of 2023


  • New York Times Bestseller

Next book

ELON MUSK

Alternately admiring and critical, unvarnished, and a closely detailed account of a troubled innovator.

Awards & Accolades

Likes

  • Readers Vote
  • 66


Our Verdict

  • Our Verdict
  • GET IT


  • Kirkus Reviews'
    Best Books Of 2023


  • New York Times Bestseller

A warts-and-all portrait of the famed techno-entrepreneur—and the warts are nearly beyond counting.

To call Elon Musk (b. 1971) “mercurial” is to undervalue the term; to call him a genius is incorrect. Instead, Musk has a gift for leveraging the genius of others in order to make things work. When they don’t, writes eminent biographer Isaacson, it’s because the notoriously headstrong Musk is so sure of himself that he charges ahead against the advice of others: “He does not like to share power.” In this sharp-edged biography, the author likens Musk to an earlier biographical subject, Steve Jobs. Given Musk’s recent political turn, born of the me-first libertarianism of the very rich, however, Henry Ford also comes to mind. What emerges clearly is that Musk, who may or may not have Asperger’s syndrome (“Empathy did not come naturally”), has nurtured several obsessions for years, apart from a passion for the letter X as both a brand and personal name. He firmly believes that “all requirements should be treated as recommendations”; that it is his destiny to make humankind a multi-planetary civilization through innovations in space travel; that government is generally an impediment and that “the thought police are gaining power”; and that “a maniacal sense of urgency” should guide his businesses. That need for speed has led to undeniable successes in beating schedules and competitors, but it has also wrought disaster: One of the most telling anecdotes in the book concerns Musk’s “demon mode” order to relocate thousands of Twitter servers from Sacramento to Portland at breakneck speed, which trashed big parts of the system for months. To judge by Isaacson’s account, that may have been by design, for Musk’s idea of creative destruction seems to mean mostly chaos.

Alternately admiring and critical, unvarnished, and a closely detailed account of a troubled innovator.

Pub Date: Sept. 12, 2023

ISBN: 9781982181284

Page Count: 688

Publisher: Simon & Schuster

Review Posted Online: Sept. 12, 2023

Kirkus Reviews Issue: Oct. 15, 2023

Next book

THINKING, FAST AND SLOW

Striking research showing the immense complexity of ordinary thought and revealing the identities of the gatekeepers in our...

A psychologist and Nobel Prize winner summarizes and synthesizes the recent decades of research on intuition and systematic thinking.

The author of several scholarly texts, Kahneman (Emeritus Psychology and Public Affairs/Princeton Univ.) now offers general readers not just the findings of psychological research but also a better understanding of how research questions arise and how scholars systematically frame and answer them. He begins with the distinction between System 1 and System 2 mental operations, the former referring to quick, automatic thought, the latter to more effortful, overt thinking. We rely heavily, writes, on System 1, resorting to the higher-energy System 2 only when we need or want to. Kahneman continually refers to System 2 as “lazy”: We don’t want to think rigorously about something. The author then explores the nuances of our two-system minds, showing how they perform in various situations. Psychological experiments have repeatedly revealed that our intuitions are generally wrong, that our assessments are based on biases and that our System 1 hates doubt and despises ambiguity. Kahneman largely avoids jargon; when he does use some (“heuristics,” for example), he argues that such terms really ought to join our everyday vocabulary. He reviews many fundamental concepts in psychology and statistics (regression to the mean, the narrative fallacy, the optimistic bias), showing how they relate to his overall concerns about how we think and why we make the decisions that we do. Some of the later chapters (dealing with risk-taking and statistics and probabilities) are denser than others (some readers may resent such demands on System 2!), but the passages that deal with the economic and political implications of the research are gripping.

Striking research showing the immense complexity of ordinary thought and revealing the identities of the gatekeepers in our minds.

Pub Date: Nov. 1, 2011

ISBN: 978-0-374-27563-1

Page Count: 512

Publisher: Farrar, Straus and Giroux

Review Posted Online: Sept. 3, 2011

Kirkus Reviews Issue: Sept. 15, 2011

Close Quickview